Acute and chronic nephrotoxicity frequently limits the therapeutic ben
efits of immunosuppressive therapy for transplant and autoimmune indic
ations. The clinical aspects, pathophysiology, and relevant pharmacolo
gy of current and future immunosuppressive drugs are reviewed in this
paper. Insights gained from experimental models of chronic nephrotoxic
ity associated with tubulointerstitial fibrosis are presented.